LIAN BRIAN (President & CEO) sold 5.5% of their position (148.52K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.95M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2026ACC: 0001193125-26-324448
DirectorOfficer· President & CEO
Since Jan 2019
+73.15K
Net shares
Net buyer
$4.95M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
221.67K acquired · 148.52K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+221.67K
Price / share
—
Trade value
—
% of position
8.9%
7/28/2026
2.50M→2.72M
Common Stock, par value $0.00001 per share
Direct
Shares
−148.52K
Price / share
$33.32
Trade value
$4.95M
% of position
5.5%
7/29/2026
2.72M→2.57M
Total
Net shares
+73.15K
Net value
-$4.95M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 7/28/2026 | A · Award | +221.67K | — | — | 8.9% | 2.50M | 2.72M |
| Common Stock, par value $0.00001 per share Direct | 7/29/2026 | S · Sale | −148.52K | $33.32 | $4.95M | 5.5% | 2.72M | 2.57M |
| Total | +73.15K | -$4.95M | ||||||
Derivative Transactions0
No derivative transactions reported